BioSpace News Archive

Phase 1 study demonstrated TERN-101 is safe and exhibits potent target engagement at all dose levels studied

Itamar Medical Ltd. announced that it will report its unaudited financial results for the fourth quarter and full year 2019 before the U.S. market opens on Tuesday, March 3, 2020.

Maxar Technologies plans to release its fourth quarter 2019 financial results after the market closes on Monday, March 2, 2020.

Transaction Provides Capital to Support Next Phase of Growth for Adolescent Behavioral Health Services Provider

IRVING, Texas , Feb. 19, 2020 /PRNewswire/ -- Caris Life Sciences ® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian Brille , Vice Chairman of the Company, will present at the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 , at 9:30 a.m. Eastern time . The confe

CRANBURY, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, March 2, 2020 at 8:30 a.m. ET to discuss financial results for the full year ended December 31, 2019. The call will be led by John F. Crowley, Chairman and Chief Executive Officer. He will be joined on the call by additional members of the Amicus senior leadership team. Interested participants and investors may acc

WASHINGTON , Feb. 19, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) announces the appointment of Stephen Ray Mitchell , M.D. to its Board of Directors. “Ray is a highly respected leader in academic medicine and globally recognized expert in Pediatrics,” said Mihael H. Polymeropoulos , M.D., President and Chief Executive Officer of Vanda. “He brings

MONMOUTH JUNCTION, N.J. and NORTH POINT, Hong Kong , Feb. 19, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader with more than 80,000 global treatments of its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients, and China Medical System Holdings Limited (C

Webcast scheduled for Wednesday, February 26th at 11:30 a.m. Eastern Time

Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced it has appointed Bommy Lee as Head of Communications.